Economic Burden for Lung Cancer Survivors in Urban China
Background: With the rapid increase in the incidence and mortality of lung cancer, a growing number of lung cancer patients and their families are faced with a tremendous economic burden because of the high cost of treatment in China. This study was conducted to estimate the economic burden and pati...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-03-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-4601/14/3/308 |
id |
doaj-528786ddd6a543ce8a92b3e8f491b34f |
---|---|
record_format |
Article |
spelling |
doaj-528786ddd6a543ce8a92b3e8f491b34f2020-11-24T23:01:56ZengMDPI AGInternational Journal of Environmental Research and Public Health1660-46012017-03-0114330810.3390/ijerph14030308ijerph14030308Economic Burden for Lung Cancer Survivors in Urban ChinaXin Zhang0Shuai Liu1Yang Liu2Jian Du3Wenqi Fu4Xiaowen Zhao5Weidong Huang6Xianming Zhao7Guoxiang Liu8Zhengzhong Mao9Teh-wei Hu10School of Public Health, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150086, ChinaGraduate School of China Academy of Chinese Medical Sciences, Beijing 100700, ChinaSchool of Public Health, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150086, ChinaDepartment of Clinic Medicine, Heilongjiang Nursing College, 209 Xuefu Road, Nangang District, Harbin 150086, ChinaSchool of Public Health, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150086, ChinaSchool of Public Health, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150086, ChinaSchool of Public Health, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150086, ChinaChinese People’s Liberation Army 211 Hospital, Harbin 150080, ChinaSchool of Public Health, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150086, ChinaWest China School of Public Health, Sichuan University, Chengdu 610041, ChinaSchool of Public Health, University of California, Berkeley 94720, CA, USABackground: With the rapid increase in the incidence and mortality of lung cancer, a growing number of lung cancer patients and their families are faced with a tremendous economic burden because of the high cost of treatment in China. This study was conducted to estimate the economic burden and patient responsibility of lung cancer patients and the impact of this burden on family income. Methods: This study uses data from a retrospective questionnaire survey conducted in 10 communities in urban China and includes 195 surviving lung cancer patients diagnosed over the previous five years. The calculation of direct economic burden included both direct medical and direct nonmedical costs. Indirect costs were calculated using the human capital approach, which measures the productivity lost for both patients and family caregivers. The price index was applied for the cost calculation. Results: The average economic burden from lung cancer was $43,336 per patient, of which the direct cost per capita was $42,540 (98.16%) and the indirect cost per capita was $795 (1.84%). Of the total direct medical costs, 35.66% was paid by the insurer and 9.84% was not covered by insurance. The economic burden for diagnosed lung cancer patients in the first year following diagnosis was $30,277 per capita, which accounted for 171% of the household annual income, a percentage that fell to 107% after subtracting the compensation from medical insurance. Conclusions: The economic burden for lung cancer patients is substantial in the urban areas of China, and an effective control strategy to lower the cost is urgently needed.http://www.mdpi.com/1660-4601/14/3/308economic burdenlung cancerdirect costindirect costmedical insuranceChina |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xin Zhang Shuai Liu Yang Liu Jian Du Wenqi Fu Xiaowen Zhao Weidong Huang Xianming Zhao Guoxiang Liu Zhengzhong Mao Teh-wei Hu |
spellingShingle |
Xin Zhang Shuai Liu Yang Liu Jian Du Wenqi Fu Xiaowen Zhao Weidong Huang Xianming Zhao Guoxiang Liu Zhengzhong Mao Teh-wei Hu Economic Burden for Lung Cancer Survivors in Urban China International Journal of Environmental Research and Public Health economic burden lung cancer direct cost indirect cost medical insurance China |
author_facet |
Xin Zhang Shuai Liu Yang Liu Jian Du Wenqi Fu Xiaowen Zhao Weidong Huang Xianming Zhao Guoxiang Liu Zhengzhong Mao Teh-wei Hu |
author_sort |
Xin Zhang |
title |
Economic Burden for Lung Cancer Survivors in Urban China |
title_short |
Economic Burden for Lung Cancer Survivors in Urban China |
title_full |
Economic Burden for Lung Cancer Survivors in Urban China |
title_fullStr |
Economic Burden for Lung Cancer Survivors in Urban China |
title_full_unstemmed |
Economic Burden for Lung Cancer Survivors in Urban China |
title_sort |
economic burden for lung cancer survivors in urban china |
publisher |
MDPI AG |
series |
International Journal of Environmental Research and Public Health |
issn |
1660-4601 |
publishDate |
2017-03-01 |
description |
Background: With the rapid increase in the incidence and mortality of lung cancer, a growing number of lung cancer patients and their families are faced with a tremendous economic burden because of the high cost of treatment in China. This study was conducted to estimate the economic burden and patient responsibility of lung cancer patients and the impact of this burden on family income. Methods: This study uses data from a retrospective questionnaire survey conducted in 10 communities in urban China and includes 195 surviving lung cancer patients diagnosed over the previous five years. The calculation of direct economic burden included both direct medical and direct nonmedical costs. Indirect costs were calculated using the human capital approach, which measures the productivity lost for both patients and family caregivers. The price index was applied for the cost calculation. Results: The average economic burden from lung cancer was $43,336 per patient, of which the direct cost per capita was $42,540 (98.16%) and the indirect cost per capita was $795 (1.84%). Of the total direct medical costs, 35.66% was paid by the insurer and 9.84% was not covered by insurance. The economic burden for diagnosed lung cancer patients in the first year following diagnosis was $30,277 per capita, which accounted for 171% of the household annual income, a percentage that fell to 107% after subtracting the compensation from medical insurance. Conclusions: The economic burden for lung cancer patients is substantial in the urban areas of China, and an effective control strategy to lower the cost is urgently needed. |
topic |
economic burden lung cancer direct cost indirect cost medical insurance China |
url |
http://www.mdpi.com/1660-4601/14/3/308 |
work_keys_str_mv |
AT xinzhang economicburdenforlungcancersurvivorsinurbanchina AT shuailiu economicburdenforlungcancersurvivorsinurbanchina AT yangliu economicburdenforlungcancersurvivorsinurbanchina AT jiandu economicburdenforlungcancersurvivorsinurbanchina AT wenqifu economicburdenforlungcancersurvivorsinurbanchina AT xiaowenzhao economicburdenforlungcancersurvivorsinurbanchina AT weidonghuang economicburdenforlungcancersurvivorsinurbanchina AT xianmingzhao economicburdenforlungcancersurvivorsinurbanchina AT guoxiangliu economicburdenforlungcancersurvivorsinurbanchina AT zhengzhongmao economicburdenforlungcancersurvivorsinurbanchina AT tehweihu economicburdenforlungcancersurvivorsinurbanchina |
_version_ |
1725638232114200576 |